{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:12:19Z","timestamp":1783483939072,"version":"3.55.0"},"reference-count":24,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2020]]},"DOI":"10.1620\/tjem.251.27","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T22:06:54Z","timestamp":1590098814000},"page":"27-30","source":"Crossref","is-referenced-by-count":15,"title":["Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication"],"prefix":"10.1620","volume":"251","author":[{"given":"Mutsuo","family":"Yamaya","sequence":"first","affiliation":[{"name":"Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University Graduate School of Medicine"},{"name":"Department of Respiratory Medicine, Tohoku University Graduate School of Medicine"},{"name":"Virus Research Center, Clinical Research Division, Sendai Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Virus Research Center, Clinical Research Division, Sendai Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University Graduate School of Medicine"},{"name":"Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Nagatomi","sequence":"additional","affiliation":[{"name":"Laboratory of Health and Sports Science, Division of Biomedical Engineering for Health and Welfare, Tohoku University Graduate School of Biomedical Engineering"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","unstructured":"Abe, T., Kinoshita, T., Matsuda, J., Ogushi, T., Kawasugi, K., Yoshimura, Y. &amp; Otomo, M. (1984) Phase I study of FUT-175: single and multiple dose study. <i>Jpn. Pharmacol. Ther.<\/i>, 12, 4941-4964 (in Japanese)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bertram, S., Dijkman, R., Habjan, M., Heurich, A., Gierer, S., Glowacka, I., Welsch, K., Winkler, M., Schneider, H., Hofmann-Winkler, H., Thiel, V. &amp; Pohlmann, S. (2013) TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. <i>J. Virol.<\/i>, 87, 6150-6160.","DOI":"10.1128\/JVI.03372-12"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bertram, S., Heurich, A., Lavender, H., Gierer, S., Danisch, S., Perin, P., Lucas, J.M., Nelson, P.S., Pohlmann, S. &amp; Soilleux, E.J. (2012) Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. <i>PLoS One<\/i>, 7, e35876.","DOI":"10.1371\/journal.pone.0035876"},{"key":"4","unstructured":"Burrell, L.M., Johnston, C.I., Tikellis, C. &amp; Cooper, M.E. (2004) ACE2, a new regulator of the renin-angiotensin system. <i>Trends Endocrinol. Metab.<\/i>, 15, 166-169."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Ferner, R.E. &amp; Aronson, J.K. (2020) Chloroquine and hydroxychloroquine in covid-19. <i>BMJ<\/i>, 369, m1432.","DOI":"10.1136\/bmj.m1432"},{"key":"6","unstructured":"Fujii, S. &amp; Hitomi, Y. (1981) New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. <i>Biochim. Biophys. Acta<\/i>, 661, 342-345."},{"key":"7","doi-asserted-by":"publisher","unstructured":"Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M.L., Lescure, F.X., Nicastri, E., Oda, R., Yo, K., Quiros-Roldan, E., Studemeister, A., et al. (2020) Compassionate use of remdesivir for patients with severe covid-19. <i>N. Engl. J. Med.<\/i>, doi: 10.1056\/NEJMoa2007016 [Epub ahead of print].","DOI":"10.1056\/NEJMoa2007016"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Hamming, I., Timens, W., Bulthuis, M.L., Lely, A.T., Navis, G. &amp; van Goor, H. (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. <i>J. Pathol.<\/i>, 203, 631-637.","DOI":"10.1002\/path.1570"},{"key":"9","unstructured":"Huang, I.C., Bosch, B.J., Li, F., Li, W., Lee, K.H., Ghiran, S., Vasilieva, N., Dermody, T.S., Harrison, S.C., Dormitzer, P.R., Farzan, M., Rottier, P.J. &amp; Choe, H. (2006) SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. <i>J. Biol. Chem.<\/i>, 281, 3198-3203."},{"key":"10","unstructured":"Kawase, M., Shirato, K., Matsuyama, S. &amp; Taguchi, F. (2009) Protease-mediated entry via the endosome of human coronavirus 229E. <i>J. Virol.<\/i>, 83, 712-721."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kawase, M., Shirato, K., van der Hoek, L., Taguchi, F. &amp; Matsuyama, S. (2012) Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. <i>J. Virol.<\/i>, 86, 6537-6545.","DOI":"10.1128\/JVI.00094-12"},{"key":"12","unstructured":"Li, G. &amp; De Clercq, E. (2020) Therapeutic options for the 2019 novel coronavirus (2019-nCoV). <i>Nat. Rev. Drug Discov.<\/i>, 19, 149-150."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., et al. (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. <i>Lancet<\/i>, 395, 565-574.","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Martinez, M.A. (2020) Compounds with therapeutic potential against novel respiratory 2019 coronavirus. <i>Antimicrob. Agents Chemother.<\/i>, 64, pii: e00399-20.","DOI":"10.1128\/AAC.00399-20"},{"key":"15","unstructured":"Minakata, D., Fujiwara, S.I., Ikeda, T., Kawaguchi, S.I., Toda, Y., Ito, S., Ochi, S.I., Nagayama, T., Mashima, K., Umino, K., Nakano, H., Yamasaki, R., Morita, K., Kawasaki, Y., Sugimoto, M., et al. (2019) Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies. <i>Int. J. Hematol.<\/i>, 109, 141-146."},{"key":"16","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz, A.E., Levi, D., Podesta, A., Gorin, J.M., Gonzalez, J., Bartellini, M.A., Munne, M.S., Cabanne, A., Flichman, D. &amp; Terg, R. (2000) Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial. <i>Gut<\/i>, 46, 427-431.","DOI":"10.1136\/gut.46.3.427"},{"key":"17","unstructured":"Ohkoshi, M. (1981) Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate. <i>Gan<\/i>, 72, 959-964."},{"key":"18","unstructured":"Pharmaceuticals and Medical Devices Agency (2018) Approved-information of camostat mesilate. http:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuSearch\/ [<i>Accessed<\/i>: April 23, 2020]) (in Japanese)."},{"key":"19","unstructured":"Sai, J.K., Suyama, M., Kubokawa, Y., Matsumura, Y., Inami, K. &amp; Watanabe, S. (2010) Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease. <i>J. Gastroenterol.<\/i>, 45, 335-341."},{"key":"20","unstructured":"Sheahan, T.P., Sims, A.C., Leist, S.R., Schafer, A., Won, J., Brown, A.J., Montgomery, S.A., Hogg, A., Babusis, D., Clarke, M.O., Spahn, J.E., Bauer, L., Sellers, S., Porter, D., Feng, J.Y., et al. (2020) Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. <i>Nat. Commun.<\/i>, 11, 222."},{"key":"21","doi-asserted-by":"crossref","unstructured":"Simmons, G., Gosalia, D.N., Rennekamp, A.J., Reeves, J.D., Diamond, S.L. &amp; Bates, P. (2005) Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. <i>Proc. Natl. Acad. Sci. USA<\/i>, 102, 11876-11881.","DOI":"10.1073\/pnas.0505577102"},{"key":"22","unstructured":"Spiegel, M., Pichlmair, A., Muhlberger, E., Haller, O. &amp; Weber, F. (2004) The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. <i>J. Clin. Virol.<\/i>, 30, 211-213."},{"key":"23","unstructured":"Yamamoto, T., Yamamura, H., Yamamoto, H. &amp; Mizobata, Y. (2016) Comparison of the efficacy of continuous i.v. infusion versus continuous regional arterial infusion of nafamostat mesylate for severe acute pancreatitis. <i>Acute Med. Surg.<\/i>, 3, 237-243."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Yamaya, M., Nishimura, H., Deng, X., Sugawara, M., Watanabe, O., Nomura, K., Shimotai, Y., Momma, H., Ichinose, M. &amp; Kawase, T. (2020) Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. <i>Respir. Investig.<\/i>, 58, 155-168.","DOI":"10.1016\/j.resinv.2019.12.005"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/251\/1\/251_27\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T14:34:43Z","timestamp":1666622083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/251\/1\/251_27\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.251.27","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}